Vantage BioTrials Celebrates its 10th Anniversary
MONTREAL, April 18, 2017 – Establishing its core values on high professionalism and always delivering accurate results, Vantage BioTrials is happy to announce its 10th anniversary. This important milestone is a sign of recognition from all our partners for the quality of our Phase I-IV clinical trial management services, delivered to international organizations throughout the world.
“Our 10th anniversary marks a crucial milestone in our existence and I would like to thank our clients, partners and service providers for their trust, as well as each and every member of our team for their dedication and professionalism”, said Vatché Bartekian, President and Founder of Vantage BioTrials. “Being competitive in today’s world, at such a high and precise level, as well as being recently awarded ‘Best in Phase I-IV Clinical Trial Management Services’ by Global Health & Pharma Magazine are achievements we are all proud of.”
“The quality of our services has been our first priority since the beginning. Ten years later, we can confidently say that we achieved all our goals and always maintained the highest level of quality to the satisfaction of Vantage BioTrials’ clients and our continued success”, added Vahé Bartekian, Co-Founder and Vice President, Quality Management.
Winner of several internationally recognized awards and achievements, producer of the Canada Talks Pharma series of conferences, Vantage BioTrials has established strong alliances with carefully selected service providers in order to complement its own offerings. “We look toward the future confidently and with enthusiasm. We see the solidity of our foundation and our growth potential, as we constantly bring new ideas for continuous innovation in the conduct of clinical trials, always with a focus on bringing safe and effective new treatments to patients in a timely and cost-effective manner”, concluded Viken Bartekian, Co-Founder and Vice President, Corporate Development.